Northeast Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Northeast Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Northeast Pharmaceutical Group Co Ltd (000597) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥274.09 Million ≈ $40.11 Million USD) by net assets (CN¥5.60 Billion ≈ $819.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Northeast Pharmaceutical Group Co Ltd (1998–2025)

Cash flow conversion efficiency of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. This chart illustrates how Northeast Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000597 share price today for real-time trading data and today's change.

Northeast Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Northeast Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Northeast Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Northeast Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see Northeast Pharmaceutical Group Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Guangzhou Zhiguang Electric Co Ltd SHE:002169	-0.008x
China Motor Corp TW:2204	0.028x
Astec Industries Inc NASDAQ:ASTE	0.016x
Farmers National Banc Corp NASDAQ:FMNB	0.034x
ODDITY Tech Ltd. Class A Ordinary Shares NASDAQ:ODD	-0.023x
Shanghai Industrial Development Co Ltd SHG:600748	0.132x
Ribo Fashion Group Co Ltd SHG:603196	0.024x
MONGOLIAN MINING CRP.REGS F:29X2	N/A

Annual Cash Flow Conversion Efficiency for Northeast Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. Review Northeast Pharmaceutical Group Co Ltd (000597) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.67 Billion ≈ $829.59 Million	CN¥1.11 Billion ≈ $161.90 Million	0.195x	+43.25%
2024-12-31	CN¥5.57 Billion ≈ $815.01 Million	CN¥758.76 Million ≈ $111.03 Million	0.136x	+19.78%
2023-12-31	CN¥5.16 Billion ≈ $754.89 Million	CN¥586.75 Million ≈ $85.86 Million	0.114x	-51.64%
2022-12-31	CN¥4.71 Billion ≈ $689.70 Million	CN¥1.11 Billion ≈ $162.22 Million	0.235x	+35.17%
2021-12-31	CN¥4.29 Billion ≈ $627.80 Million	CN¥746.51 Million ≈ $109.24 Million	0.174x	+25.63%
2020-12-31	CN¥4.12 Billion ≈ $603.21 Million	CN¥570.92 Million ≈ $83.54 Million	0.138x	+53.89%
2019-12-31	CN¥3.92 Billion ≈ $573.30 Million	CN¥352.60 Million ≈ $51.60 Million	0.090x	+13.42%
2018-12-31	CN¥3.59 Billion ≈ $525.75 Million	CN¥285.09 Million ≈ $41.72 Million	0.079x	+167.13%
2017-12-31	CN¥2.55 Billion ≈ $372.85 Million	CN¥-301.20 Million ≈ $-44.07 Million	-0.118x	-174.83%
2016-12-31	CN¥2.43 Billion ≈ $356.17 Million	CN¥384.51 Million ≈ $56.27 Million	0.158x	+280.44%
2015-12-31	CN¥2.40 Billion ≈ $351.34 Million	CN¥99.70 Million ≈ $14.59 Million	0.042x	+144.00%
2014-12-31	CN¥2.76 Billion ≈ $404.05 Million	CN¥46.99 Million ≈ $6.88 Million	0.017x	+110.22%
2013-12-31	CN¥1.60 Billion ≈ $233.99 Million	CN¥-266.38 Million ≈ $-38.98 Million	-0.167x	-438.70%
2012-12-31	CN¥1.75 Billion ≈ $256.13 Million	CN¥86.09 Million ≈ $12.60 Million	0.049x	+136.74%
2011-12-31	CN¥1.74 Billion ≈ $255.03 Million	CN¥-233.32 Million ≈ $-34.14 Million	-0.134x	-208.03%
2010-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥255.96 Million ≈ $37.46 Million	0.124x	-58.68%
2009-12-31	CN¥2.05 Billion ≈ $300.50 Million	CN¥615.91 Million ≈ $90.13 Million	0.300x	-33.40%
2008-12-31	CN¥1.57 Billion ≈ $230.40 Million	CN¥709.03 Million ≈ $103.75 Million	0.450x	+101.66%
2007-12-31	CN¥889.22 Million ≈ $130.12 Million	CN¥198.56 Million ≈ $29.06 Million	0.223x	+295.39%
2006-12-31	CN¥927.49 Million ≈ $135.72 Million	CN¥-106.00 Million ≈ $-15.51 Million	-0.114x	-192.34%
2005-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥111.40 Million ≈ $16.30 Million	0.124x	-48.16%
2004-12-31	CN¥884.02 Million ≈ $129.36 Million	CN¥211.06 Million ≈ $30.88 Million	0.239x	-9.70%
2003-12-31	CN¥870.26 Million ≈ $127.35 Million	CN¥230.08 Million ≈ $33.67 Million	0.264x	+46.67%
2002-12-31	CN¥873.28 Million ≈ $127.79 Million	CN¥157.41 Million ≈ $23.03 Million	0.180x	+101.95%
2001-12-31	CN¥883.36 Million ≈ $129.26 Million	CN¥78.84 Million ≈ $11.54 Million	0.089x	+123.72%
2000-12-31	CN¥905.53 Million ≈ $132.51 Million	CN¥36.13 Million ≈ $5.29 Million	0.040x	-36.48%
1999-12-31	CN¥869.73 Million ≈ $127.27 Million	CN¥54.62 Million ≈ $7.99 Million	0.063x	+926.23%
1998-12-31	CN¥999.14 Million ≈ $146.21 Million	CN¥-7.59 Million ≈ $-1.11 Million	-0.008x	--

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$920.83 Million

CN¥6.29 Billion CNY

Market Cap Rank

#8895 Global

#2082 in China

Share Price

CN¥4.41

Change (1 day)

+1.15%

52-Week Range

CN¥4.20 - CN¥5.86

All Time High

CN¥133.00